Genenta Science S.p.A. Operating Cash Flow
Genenta Science S.p.A. (GNTA) reported Operating Cash Flow of -EUR 6.87 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-04-01
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|
| 2025-12-31 | -6.87M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | -5.52M EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | -6.24M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | -2.06M EUR 6-K · filed 2025-10-10 | |
| 2023-12-31 | -11.21M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | -7.58M EUR 6-K · filed 2024-10-29 | |
| 2022-12-31 | -7.42M EUR 20-F · filed 2025-03-28 | |
| 2022-06-30 | -2.57M EUR 6-K · filed 2023-10-20 | |
| 2021-12-31 | -6.96M EUR 20-F · filed 2024-03-29 | |
| 2021-06-30 | -4.69M EUR 6-K · filed 2022-10-25 | |
| 2020-12-31 | -6.04M EUR 20-F · filed 2023-04-21 | |
| 2019-12-31 | -2.49M EUR 20-F · filed 2022-05-02 |